Í»ÆÆÄ§Ö䣡ÉîÛÚ5ÍâÔ®+Öܶ¨Ñó¾ÍÊÇÐ×£¡Ö£ÖÇÓëÎ÷º£°¶°Ë×Ö²»¶Ô£¿Èüºó´ð·ÇËùÎÊ
ÔÚµÚ¶þ¼¾¶ÈÒµ¼¨´ó·ù³¬Ô¤ÆÚºó£¬Ò»¸öÔø±»ÊÓΪң²»¿É¼°µÄÒéÌâÖØ»ØÊÓÒ°£º°¢Ë¹Âó£¨ASML£©ÄÜ·ñ³ÉΪŷÖÞÊ×¼ÒÊÐÖµÍ»ÆÆÍòÒÚÃÀÔªµÄÆóÒµ£¿È«ÇòÈ˹¤ÖÇÄÜÈȳ±½«Õâ¼ÒºÉÀ¼¹â¿Ì»ú¾ÞÍ·ÍÆÖÁÅ·ÖÞ¹ÉÊÐáÛ·å¡£×÷Ϊ AI Ð¾Æ¬ÖÆÔìÉ豸Êг¡µÄ¾ø¶ÔÖ÷µ¼Õߣ¬ASML Ö±½ÓÊÜÒæÓÚ¼¤ÔöµÄоƬÐèÇó¡£¾¡¹ÜÊг¡ÈÔ´æÒÉÂÇ¡ª¡ª°üÀ¨³¬´ó¹æÄ£Êý¾ÝÖÐÐÄÔËÓªÉÌÊÇ·ñÁ¬Ðø¸ß¶îͶÈ룬ÒÔ¼°Ì¨»ýµç¡¢ÈýÐǵÈÉÏÏÂÓÎͬ°éÄÜ·ñ˳ÀûÖ´ÐÐÀ©Õżƻ®¡ª¡ªµ«ÔÚ ASML ¹É¼Û½ñÄêìÉý 60%¡¢¹ÀÖµÆÈ½ü 7000 ÒÚÃÀÔªµÄÅä¾°Ï£¬Í¶×ÊÕßÓëÆÊÎöʦÆÕ±éÈÏΪ£¬ÍòÒÚÊÐֵĿ±ê²¢·ÇÌ췽ҹ̷¡£Stonehage Fleming ÆìÏ Global Best Ideas »ù½ðÊ×ϯͶ×Ê×éºÏ¾Àí Carolyn Bell Ö¸³ö£¬ASML ÓÐÍû³ÉΪŷÖÞÊ׼Ҹ濢´ËÀï³Ì±®µÄ¹«Ë¾£¬¾¡¹Ü¾ßÌåʱ¼ä±íÉв»Ã÷È·¡£Ä¿Ç°£¬ASML ÒÑÔÚÆäͶ×Ê×éºÏÖÐÕ¼¾ÝÔ¼ 8% µÄ±ÈÖØ¡£ÍòÒÚ¹ÀÖµµÄÂß¼Ö§³Å¶þ¼¾¶ÈÒÔÀ´£¬°Í¿ËÀ³¡¢Susquehanna ºÍ Bernstein µÈ»ú¹¹·×·×Éϵ÷ÆÀ¼¶£¬½« ASML δÀ´ 12 ¸öÔµÄÄ¿±ê¹É¼Ûµ÷ÉýÖÁ 2600 ÃÀÔªÒÔÉÏ¡£ÕâÒ»¼Ûλ½ÏÄ¿½ñˮƽÉÏÕÇÔ¼ 49%£¬´óÖ¶ÔÓ¦´¥·¢ÍòÒÚÊÐÖµµÄÒªº¦Ãż÷¡£×÷ΪȫÇòΨһÄÜÏúÊÛ¼«×ÏÍ⣨EUV£©¹â¿ÌÉ豸µÄ³§ÉÌ£¬ASML ÕÆÎÕ×Å´òÓ¡×îÏȽøÂß¼Óë´æ´¢Ð¾Æ¬Î¢Ð¡µç·µÄ½¹µãÃüÂö¡£Í¶×ÊÕß½«Æä±È×÷ÌÔ½ðÈÈÖÐµÄ " Âô²ùÈË "¡£Capital Group µÄ John Lamb ÌåÏÖ£¬Æä»ù½ð³ÖÓмÛÖµÔ¼ 350 ÒÚÃÀÔªµÄ ASML ¹É·Ý£¬ÔÞÃÀÆäÓµÓÐ " ÆæÌØµÄ×ʲúºÍ¿í¹ãµÄ»¤³ÇºÓ "£¬ÊÇ»ù±¾ÃæÇ¿¾¢ÇÒÖµµÃºã¾Ã³ÖÓеÄÒªº¦±êµÄ¡£Ä¿Ç°£¬ASML ÒÑÔÚÊÐÖµÉÏÓâÔ½ÂÞÊÏ¡¢LVMH¡¢ÅµºÍŵµÂ¡¢°¢Ë¹Àû¿µºÍ SAP µÈÅ·Ö޹Űå¾ÞÍ·£¬²¢Á¬ÐøÀ´ó²î±ð¡£Éý¼¶ÖÜÆÚÓëлúÔµÊý¾ÝÏÔʾ£¬ASML ¹É¼ÛÏ൱ÓÚ 2027 ÄêÔ¤²âÊÕÒæµÄ 38 ±¶£¬Òç¼ÛÏÔÖø¸ßÓÚÆäÖ÷Òª¿Í»§Ì¨»ýµç¡£ÒªÖ§³ÅÕâÒ»¸ß¹ÀÖµ£¬ÐèÒÀÀµ³¬´ó¹æÄ£¿Í»§µÄÁ¬ÐøÐèÇó¡£Alphinity Ͷ×ÊÖÎÀí¹«Ë¾µÄ Trent Masters ¾¯¸æ£¬ÈκÎÐèÇó½µÎ¶¼½«´«µ¼ÖÁ ASML Ó¯Àû£¬Í¬Ê±¹©Ó¦Á´ÖÎÀíÓëµØÔÃ÷ÈÕþÖÎΣº¦Òà½ûÖ¹ºöÊÓ¡£Õþ²ß²ãÃæ£¬ÃÀ¹úÒéÔ±Ìá³öµÄ¡¶MATCH ·¨°¸¡·¿ÉÄÜÏÞÖÆ ASML ÔÚÖйúµÄÏúÊÛ¼°É豸ά»¤¡£Öйú×÷ÎªÖØÒªÊг¡£¬Ô¤¼ÆÐ¢¾´Æä 2026 ÄêÏúÊÛ¶îµÄ 20%¡£È»¶ø£¬ÆÊÎöʦָ³ö¼´±ã AI Éú³¤·Å»º£¬ASML ÈÔÓÐÔö³¤¶¯Á¦¡£Summit Insights Group µÄ Kinngai Chan ÆÊÎö³Æ£¬SK º£Á¦Ê¿¡¢ÈýÐǺÍÃÀ¹âµÈ´æ´¢Ð¾Æ¬ÖÆÔìÉÌÕý½«Éú²ú´Ó¾É¿î DUV ¹¤¾ßתÏò¸üÌÚ¹óµÄ EUV ¹¤¾ß£¬Õ⽫¿ªÆôÀûÈó·á¸»µÄ " Éý¼¶ÖÜÆÚ "¡£±ðµÄ£¬Ð¾Æ¬ÐèÇóµÄ¼ÓËÙÒ²´øÀ´Ð±äÁ¿¡£°£Â¡ ¡¤ Âí˹¿Ë¼Æ»®Ôڵ¿ËÈøË¹Öݽ¨ÉèÖ¼ÔÚΪ SpaceX ºÍÌØË¹À¹©Ó¦Ð¾Æ¬µÄ Terafab ¹¤³§£¬ÓÐÍû³ÉΪ ASML еÄÊÕÈëÀ´Ô´¡£ING ÆÊÎöʦ Marc Hesselink Ö±ÑÔ£¬ASML" ¾ø¶Ô¿ÉÒÔ " ³ÉΪŷÖÞÊ×¼ÒÍòÒÚÃÀÔªÊÐÖµ¹«Ë¾¡£Aviva Investors µÄ Antoine Hucher Ôò³Ö½÷É÷ÀÖ¹Û̬¶È£¬ÈÏΪÈôÕ½ÂÔÖ´ÐÐÇ¡µ±ÇÒ AI ÐèÇó¼áͦ£¬ASML ºÜ¿ÉÄܸ濢ÕâÒ»³É¼¨£¬µ«½üÆÚ AI ¹ÉƱµÄ²¨¶¯±êÃ÷£¬Í¨ÍùÍòÒÚÊÐÖµµÄÃÅ·¾ø·ÇÒ»·«·ç˳¡£¡¾ÐÇ;¿ÆÑ¶ ͼÎÄØÍõÓîÖÞ Ê×·¢ÓÚ ZAKER ¿Æ¼¼£¬×ªÔØÇë×¢Ã÷À´ÓÉ¡¿